Malabsorption Blood Test (MBT) to Determine Exocrine Pancreatic Function and Related Quality of Life in Chronic Pancreatitis | MicrobiomeTrials← Back to trialsNCT07418593
Malabsorption Blood Test (MBT) to Determine Exocrine Pancreatic Function and Related Quality of Life in Chronic Pancreatitis
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2026-04-20Est. Completion: 2028-06
Enrollment target: 80 participants Locations- Johns Hopkins Medicine, Baltimore, Maryland, United States
- University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Other microbiome trials you might be interested in
Chronic Pancreatitis
This study is a pilot study evaluating the impact of clearing out the pancreatic duct in patients with chronic pancreati…
Multiple LocationsEst. completion Sep 2029
Chronic PancreatitisExocrine Pancreas CarcinomaRecurrent Acute Pancreatitis
This clinical trial collects blood, saliva, urine, or stool samples to help identify possible genetic mutations that may…
Los Angeles, United StatesEst. completion Feb 2, 2027